Bernard Fermini
Corporate Officer/Principal presso Society of Toxicology
Profilo
Bernard Fermini is a member of the Society of Toxicology and the Health & Environmental Sciences Institute.
He was previously the Director of the Safety Pharmacology Society and the Head-Ion Channel Discipline at Pfizer Inc. He also served as the Chief Research & Development Officer at Novoheart Holdings, Inc. and the Chief Scientific Officer & VP-Toxicology at Coyne Scientific LLC.
Fermini received his undergraduate degree from the University of Montréal and his doctorate from the University of Sherbrooke.
He is currently employed in his roles at the Society of Toxicology and the Health & Environmental Sciences Institute.
Posizioni attive di Bernard Fermini
| Società | Posizione | Inizio |
|---|---|---|
Society of Toxicology
 Society of Toxicology Miscellaneous Commercial ServicesCommercial Services The Society of Toxicology is an organization that unites 8,000 professionals in the field of toxicology from all over the world. The non-profit company is based in Reston, VA. The company's goal is to promote scientific advancements and provide support to toxicologists. | Corporate Officer/Principal | - |
| Health & Environmental Sciences Institute | Corporate Officer/Principal | - |
Precedenti posizioni note di Bernard Fermini
| Società | Posizione | Fine |
|---|---|---|
| NOVOHEART HOLDINGS INC. | Direttore Tecnico/Scientifico/R&S | 31/07/2020 |
| Coyne Scientific LLC | Direttore Tecnico/Scientifico/R&S | 01/08/2018 |
| PFIZER, INC. | Corporate Officer/Principal | 01/10/2016 |
| Safety Pharmacology Society | Direttore/Membro del Consiglio | - |
Formazione di Bernard Fermini
| University of Montréal | Undergraduate Degree |
| University of Sherbrooke | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Novoheart Holdings, Inc.
 Novoheart Holdings, Inc. BiotechnologyHealth Technology Novoheart Holdings, Inc. is a global stem cell biotechnology company. It engages in engineering prototypes of bio-artificial human heart tissues and chambers for drug discovery, cardio toxicity screening, diseases modeling and therapeutic applications. The firm products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Anisotropic Patch (hvCAP), Cardiac Tissue Strip (hvCTS), and novoHeart. The company was founded by Michelle Khine, Kevin Costa and Ronald Li on April 28, 1964 and is headquartered in Vancouver, Canada. | Health Technology |
| Coyne Scientific LLC | |
Society of Toxicology
Society of Toxicology Miscellaneous Commercial ServicesCommercial Services The Society of Toxicology is an organization that unites 8,000 professionals in the field of toxicology from all over the world. The non-profit company is based in Reston, VA. The company's goal is to promote scientific advancements and provide support to toxicologists. | Commercial Services |
| Health & Environmental Sciences Institute | |
| Safety Pharmacology Society |
- Borsa valori
- Insiders
- Bernard Fermini
